Axenya, a health technology company specializing in the intelligent orchestration of corporate healthcare, has recently announced a successful Series A funding round totaling $12 million. The funding was led by Canary, with Indicator Capital co-leading and Zentynel participating. This investment aims to support Axenya’s strategic efforts to expand its commercial reach and enhance its technological platform, with a focus on advancements in artificial intelligence, data interoperability, and connected biomarkers.
Axenya adopts an integrated approach by connecting companies, employees, insurers, and healthcare providers through sophisticated technological infrastructure and data intelligence. Its platform consists mainly of two components: LifeVault and Axenya IQ.
LifeVault operates as an interoperable data lake, consolidating clinical, operational, and administrative information to enable seamless data access and management. Meanwhile, Axenya IQ is a predictive engine powered by artificial intelligence and generative AI, designed to anticipate health risks, recommend interventions, and streamline patient care pathways.
The results reported by Axenya’s clients highlight significant improvements in healthcare efficiency and cost management. Clients observed medical inflation rates up to 50% lower than market averages, with loss ratios reduced by approximately 1,500 basis points compared to national standards.
Additionally, clients experienced a 22% decrease in total healthcare expenses year-over-year and a 40% reduction in costs associated with managing high-risk patients. The company also reported that costs per procedure or consultation were reduced by half, despite a 13% increase in appointments, indicating improved efficiency and resource utilization.
Through these innovations and growth, Axenya is positioning itself as a transformative player in corporate healthcare, leveraging advanced technology to deliver more efficient, cost-effective, and predictive healthcare solutions for organizations and their employees.
KEY QUOTES:
“In healthcare, having a great product isn’t enough—you need a business model that can reshape the system. That’s what sets Axenya apart.”
Mariano Garcia-Valiño, founder and CEO of Axenya
“Axenya impressed us with its innovative approach and proven results in reducing steep annual health plan cost increases for companies and their employees, while improving care for patients with critical conditions.”
Kristian Huber, General Partner at Canary
“We believe Axenya is building the technological infrastructure needed to revolutionize corporate health management in Brazil. Indicator’s role is to accelerate this transformation by integrating data, devices, and predictive intelligence—key elements to reshape population health in one of the country’s most challenging and underserved markets.”
Thomas Bittar, co-founder of the leading deep tech fund in Latin America
